Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis

[1]  David T. W. Jones,et al.  Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome , 2017, Brain pathology.

[2]  P. Park,et al.  The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers , 2017, Nature Communications.

[3]  T. Wieland,et al.  Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin–Siris syndrome-like phenotype , 2017, Human Genetics.

[4]  D. Cooper,et al.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis , 2016, Human Genetics.

[5]  Shawn M. Gillespie,et al.  SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation , 2016, Nature Genetics.

[6]  A. Berchuck,et al.  The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases , 2016, Familial Cancer.

[7]  S. Navarro,et al.  BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways , 2016, Oncogene.

[8]  W. Foulkes,et al.  Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis. , 2016, Surgical pathology clinics.

[9]  G. Stein,et al.  The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation , 2016, Oncotarget.

[10]  J. Staiger,et al.  Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development , 2016, Cell cycle.

[11]  P. Varlet,et al.  The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation , 2016, Nature Communications.

[12]  D. Evans,et al.  A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening , 2016, neurogenetics.

[13]  J. Biegel,et al.  Report of a patient with a constitutional missense mutation in SMARCB1, Coffin–Siris phenotype, and schwannomatosis , 2015, American journal of medical genetics. Part A.

[14]  O. A. Abdul-Rahman.  Nicolaides-Baraitser Syndrome , 2015 .

[15]  A. D. Dei Tos,et al.  Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis. , 2015, Human pathology.

[16]  G. Crabtree,et al.  Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics , 2015, Science Advances.

[17]  M. Smith.  Germline and somatic mutations in meningiomas. , 2015, Cancer genetics.

[18]  I. Rzepecka,et al.  Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type , 2015, Orphanet Journal of Rare Diseases.

[19]  S. Sredni,et al.  Rhabdoid Tumor Predisposition Syndrome , 2015, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[20]  R. Hevner,et al.  Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas , 2014, The Journal of pathology.

[21]  J. Biegel,et al.  SWI/SNF chromatin remodeling complexes and cancer , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[22]  David Evans,et al.  SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. , 2014, Cancer genetics.

[23]  R. Hennekam,et al.  Phenotype and genotype in Nicolaides–Baraitser syndrome , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[24]  J. Biegel,et al.  Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion. , 2014, Cancer genetics.

[25]  R. Siebert,et al.  SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis , 2014, Acta Neuropathologica.

[26]  J. Vengoechea,et al.  Papillary thyroid cancer in a patient with interstitial 6q25 deletion including ARID1B , 2014, American journal of medical genetics. Part A.

[27]  N. Matsumoto,et al.  Coffin–Siris syndrome is a SWI/SNF complex disorder , 2014, Clinical genetics.

[28]  C. Antonescu,et al.  Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material , 2014, Genes, chromosomes & cancer.

[29]  P. Modena,et al.  Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS) , 2014, Pediatric blood & cancer.

[30]  F. Baas,et al.  Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors , 2014, Acta Neuropathologica.

[31]  R. Siebert,et al.  Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type , 2014, Nature Genetics.

[32]  P. Wesseling,et al.  SMARCB1 Involvement in the Development of Leiomyoma in a Patient With Schwannomatosis , 2014, The American journal of surgical pathology.

[33]  Wei Song,et al.  Recent advances in the ARID family: focusing on roles in human cancer , 2014, OncoTargets and Therapy.

[34]  K. Devriendt,et al.  A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. , 2013, Human molecular genetics.

[35]  A. V. Vulto-van Silfhout,et al.  Coffin–Siris Syndrome and the BAF Complex: Genotype–Phenotype Study in 63 Patients , 2013, Human mutation.

[36]  T. Owen-Hughes,et al.  Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling Enzymes , 2013, Cell.

[37]  G. Crabtree,et al.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.

[38]  A. Stemmer-Rachamimov,et al.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria , 2013, American journal of medical genetics. Part A.

[39]  D. Eccles,et al.  Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas , 2013, Nature Genetics.

[40]  O. Delattre,et al.  Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations. , 2012, The American journal of surgical pathology.

[41]  Giovanni Parmigiani,et al.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.

[42]  Christian Gilissen,et al.  Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. , 2012, American journal of human genetics.

[43]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[44]  Tadashi Kaname,et al.  New from NPG , 2012, Nature Medicine.

[45]  F. Baas,et al.  Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri , 2012, neurogenetics.

[46]  J. Biegel,et al.  Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system , 2011, Pediatric blood & cancer.

[47]  D. Rakheja,et al.  Immunohistochemical Expression of Embryonic Stem Cell Markers in Malignant Rhabdoid Tumors , 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[48]  N. André,et al.  Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor , 2011, Clinical Cancer Research.

[49]  J. Biegel,et al.  Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors , 2011, Pediatric blood & cancer.

[50]  R. Siebert,et al.  Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. , 2010, American journal of human genetics.

[51]  L. Kluwe,et al.  Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis , 2008, Clinical genetics.

[52]  J. Biegel,et al.  Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1 , 2008, Journal of Medical Genetics.

[53]  A. Stemmer-Rachamimov,et al.  Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic Schwannomas , 2008, Brain pathology.

[54]  F. Baas,et al.  Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome , 2007, British Journal of Cancer.

[55]  J. Biegel,et al.  Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation , 2006, Pediatric blood & cancer.

[56]  J. Kusukawa,et al.  Coffin-Siris Syndrome , 2003 .

[57]  J. Drake,et al.  Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. , 2000, American journal of human genetics.

[58]  K. Hoang-Xuan,et al.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. , 1999, Human molecular genetics.

[59]  O. Delattre,et al.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.

[60]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[61]  F. Sangiuolo,et al.  Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism , 2015, Familial Cancer.

[62]  C. Roberts,et al.  ARID1A mutations in cancer: another epigenetic tumor suppressor? , 2013, Cancer discovery.

[63]  A. Folpe,et al.  Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. , 2012, The American journal of surgical pathology.

[64]  G. Santen,et al.  SWItching from malignancies to intellectual disability , 2012 .

[65]  J. Biegel,et al.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.